A close-up of six Emory discoveries. Click images for more.
Click headshot for research details Click headshot for research details Click headshot for research details Click headshot for research details Click headshot for research details Click headshot for research details

ALS Clinical Trial Tests Safety of Neural Stem Cells

Researchers are hoping neural stem cells injected directly into the spine can help treat patients with amyotrophic lateral sclerosis (ALS). Lou Gehrig’s disease is a fatal neurodegenerative disease with no known cure. Emory began the first U.S. clinical trial in January, using cells developed by Neuralstem, a Maryland biotech company. The cultured neural stem cells may be able to mature into motor neurons or at least slow progression of ALS. Neurologist Jonathan Glass (pictured) is directing a phase I study at Emory to assess safety of the procedure and the cells. Neurosurgeon Nicholas Boulis performs the surgery, and University of Michigan scientist Eva Feldman directs the overall program. Full story >